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decompression with small diameter PTFE interposi-
tion grafts.
The confirmation of Sarfeh’s experience of durable
patency with the use of small diameter ringed PTFE
interposition prosthetic grafts appears to have allayed
residual reservations about this procedure. Further
experience over more extended periods will be required
to establish whether it will truly match the excellent
long term patency rate and functional results of the
DSRS. In my view it has established a place in the
operative therapeutic armamentarium for portal hy-
pertension, especially for patients where a DSRS is
impossible, for example patients who have undergone
a,previous ill advised splenectomy. The technical sim-
plicity and safety of this procedure are also appealing
in the less common context of emergency shunting,
although it is doubtful whether it will have a major
impact on the much greater operative mortality experi-
enced with all forms of emergency operative interven-
tion in Childs grade C patients.
2. Johansen, K. (1992) Prospective comparison of partial versus
total portal decompression for bleeding esophageal varices. Surg.
Gynecol. Obstel., 175, 528-34.
3. Myburgh, J. A. (1990) Selective shunts: the Johannesburg experi-
ences. Am. J. Surg., 16t), 67-72.
4. Warren, W. D., Millikan, W. J. and Henderson, J. M. et al. (1984)
Selective variceal decompression after splenectomy or splenic vein
thrombosis with a note on splenopancreatic disconnection. Ann.
Surg., 199, 694-72.
5. Myburgh, J. A. (1991)The Warren shunt: Effect ofalocoholism on
portal perfusion. Discussion on paper by Kawasaki, S. et al. HPB
Surgery, 5, 70-73.
6. Johansen, K.H., Girod, C., Lee, S.S. and Lebrec, D. (1990)
Mesenteric venous stenosis reduces hyper-ammonemia in the
portacaval shunted rat. Eur. Surg. Res., 22,’170-74.
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GASTRIC VARICES: FIRST YOU HAVE TO SEE THEM
ABSTRACT
Sarin, S.K., Iahoti, D., Saxena, S.P., Murthy, N.S., and Makwana, U.K. (1992)
Prevalence, Classification and Natural History of Gastric Varices: A longtermfollow-up
study in 568 portal hypertension patients. Hepatology, 16, 1343-1349.
To determine the prevalence and natural history of gastric varices, we prospectively
studied 568 patients (393 bleeders and 175 nonbleeders) with portal hypertension
(cirrhosis in 301 patients, noncirrhotic portal fibrosis in 115 patients, extrahepatic portal
vein obstruction in 117 patients and hepatic venous outflow obstruction in 35 patients).
Primary (present at initial examination) gastric varices were seen in 114 (20%) patients;
more were present in bleeders than in nonbleeders (27% vs. 4%, respectively; p < 0.001).
Secondary (occurring after obliteration of esophageal varices) gastric varices developed
in 33 (9%) patients during follow-up of 24.6__+ 5.3 too. Gastric varices (compared with
esophageal varices) bled in significantly fewer patients (25% vs. 64%, respectively).
Gastric varices had a lower bleeding risk factor than did esophageal varices (2.0_ 0.5 vs.
4.3 +__ 0.4, respectively) but bled more severely (4.8 _+ 0.6 vs. 2.9 ___
0.3 transfusion units per
patient, respectively). Once a varix bled, mortality was more likely (45%) in gastric varix60 HPB INTERNATIONAL
patients. Gastric varices were classifed as gastroesophageai or isolated gastric varices.
Type 1 gastroesophageal varices (lesser curve varices) were the most common (75%).
After obliteration of esophageal varices, type 1 gastroesophageal varices disappeared in
59% of patients and persisted in the remainder; bleeding from persistent gastro-
esophageal varices was more common than it was from gastroesophageal varices that
were obliterated (28% vs. 2%, respectively; p < 0.001). Type 2 gastroesophageal varices,
which extend to greater curvature, bled often (55%) and were associated with high
mortality. Type 1 isolated gastric varices patients had only fundal varices, with a high
(78%) incidence of bleeding. Type 2 isolated gastric varices were mainly (86%) ectopic
secondary gastric varices that bled only rarely (9%). Sclerotherapy was more effective in
controlling acute bleeding and obliterating varices in gastroesophageai varices than in
isolated gastric varices; the latter often required surgery. In conclusion, gastric varices are
a common and serious complication ofportal hypertension. Our classification was helpful
in understanding the natural history and management of gastric varices. (HEPATOLOGY
1992; 16:1343-1349.)
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PAPER DISCUSSION
Gastric varices attracted little interest until injection
sclerotherapy became used widely. Previously, many
patients with portal hypertension who bled from any
varix would undergo shunt surgery irrespective of the
site of bleeding. With the widespread adoption of
sclerotherapy, precise identification of the bleeding
point became essential, but the effectiveness of sclero-
therapy in controlling bleeding from oesophageal vari-
ces was not seen when applied to gastric varices. Impre-
cise terminology and limited, almost anecdotal reports
did not help. Fortunately, there have been several
studies in the last five years which have made serious
attempts to document the prevalence, distribution,
bleeding, risk and treatment strategies of gastric vari-
ces. Sarin and colleagues have written such a paper.
In their study, gastric varices (GVs) were classified
along similair lines to those proposed by ourselves
and Korula et al. 2. Five hundred and sixtyeight pa-
tients with portal hypertension underwent endoscopy
by two independent observers. Gastric varices were
recorded when both observers agreed on their presence
and distribution. Four main types were described:
1) Lesser curve GVs which were an extension of
oesophageal varices (OVs)
2) Fundal GVs which were continuous with OVs
3) Fundal GVs with no OVs
4) Antroduodenal GVs with no OVs.
Twenty per cent of their patients had GVs. The vast
majority ofGVs (76%)were located on the lesser curve.
Treatment of GVs was reserved until they bled but all
OVs, whether they had bled or not, underwent scler-
otherapy. After injecting OVs, Sarin and colleagues
reported that many GVs, disappeared, a feve appeared
and the remainder were unchanged. Of greater clinical
importance is that 12% oflesser curve GVs and 55% of
fundal GVs bled: almost half of those who bled died.
Such mortality is considerably more than that ofbleed-
ing OVs.
This paper confirms some ofwhat has been reported
already but raises another very important issue, that
of the considerable variation seen in series on GVs.
For example, gastric varices have been generally
reported in 10-36% of patients who have OVs
(some series 0-100%), the prevalence of lesser
curve GVs is reported as 4-35% of patients and that
of secondary GVs appearing after OV sclerotherapy
as 9-30%. These variations deserve closer examina-
tion.
Portal hypertension is a progressive condition. The
point at which a patient is examined for GVs (and OVs
or any other varix) therefore becomes all important.
Sarin et al., report that 69% of their cohort had
a bleeding history but the site (cause) is not stated.
Hence the statement that GVs were more common in
patients who had bled does not allow us to stage
patients accurately in their chronology ofportal hyper-
tension. The remaining 31% had not bled. This prob-HPB INTERNATIONAL 61
lem ofheterogeneity creeps into many series and makes
interpretation of prevalence figures very hard to com-
pare from one series to another. We know that the
aetiology ofportal hypertension is not important to the
development ofOVs and this seems to be true for GVs.
Severity of liver disease may be important and is an
unfortunate omission from this paper.
How is a GV diagnosed? In theory there should be
no difficulty in recognizing a GV via an endoscope.
Unfortunately this is far from easy unlike OVs where
observer variation is acceptably small. Sarin et al.,
make a serious attempt to overcome this problem by
use of 2 observers. Such a technique might, if anything,
underestimate the presence ofGVs although we cannot
estimate by how much as observer variation was not
stated. Attention is rightly drawn to the necessity offull
insufflation of the stomach and also to the particular
problems ofendoscopic examination immediately after
a bleed. One wonders whether all observers routinely
examine the fundus once a bleeding OV has been
diagnosed particularly when the stomach is full of
blood. Others have advocated splenoportography
rather than endoscopy to demonstrate GVs. In a com-
parative study ofsplenoportography and endoscopy in
93 patients, there was good correlation between the
two methods with respect to lesser curve varices (which
are the simplest to diagnose) but endoscopy diagnosed
more fundal varices 3. What splenoportography cannot
demonstrate is the proximity ofGVs to gastric mucosa,
in other words, the likelihood of bleeding. At present
simple endoscopic examination is not always sensitive
enough to see GVs and the development of techniques
to enhance their appearance would be worthwhile.
This becomes all important iftreatment is to be admin-
istered via the endoscope.
What of treatment? A proportion will bleed (25%
over 2 years in Sarin’s paper) but certain principles
have emerged from recent series. Most reports suggest
that lesser curve varices respond well to sclerotherapy
with reasonable immediate and long term control
of bleeding and acceptable complication rates. The
approach to bleeding fundal varices is less clear.
They bleed more often (55%-75%) than lesser curve
GVs (5%-12%) and the results of scleroptherapy
are generally dissappointing. Sarin et al., achieved
long term control in about half of 17 patients and
similar or worse results are reported by others. Tem-
porary control of bleeding followed by something
other than sclerotherapy, such as surgery or possibly
drugs, seems to be the way forward. The same seems to
be true for isolated antral varices although these are
uncommon.
A recurring question is what effect sclerosing OVs
has on GVs. Sarin et al., provide us with additional
data. They found that lesser curve GVs disappeared in
59% of patients after sclerosing OVs and appeared
(secondary GVs) in 9% of patients. Interestingly the
proportion of primary and secondary GVs that bled
was similair. Only 17/’0 of fundal varices disappeared.
We reported a similair incidence of secondary GVs
(10%) but others report figures of around 50%. Once
again observer variation and methods of data collec-
tion seem more likely explanations than a true differ-
ence. Why OV sclerotherapy should cause some GVs
to appear and others to disappearmay be related to the
direction of blood flow in OVs. Caudad flow will carry
the sclerosant into GVs whereas cephalad flow will do
the opposite. The location of perforating veins in this
junctional area may also influenceGV blood flow after
sclerosis of OVs’.
In conclusion several studies now concur that in
patients with OVs there are 2 broad groups of GVs
(lesser curve and fundal) which differ in prevalence,
morphology bleeding risk and reponse to scler-
otherapy. Isolated GVs either due to splenic vein oc-
clusion or generalized portal hypertension are rare and
data collection will be much more difficult for this
group. Sarin and his collegues have made a valuable
contribution to our knowledge of GVs particularly
with their thorough technique of examination and
recording ofdata. Future studies ofGVs would do well
to follow the same path.
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